Politics Rachel Cohrs STAT Plus: In new Regeneron deal for Covid drug, White House imposes price limits for first time
First Opinion Arjun Sharma STAT Plus: PEPFAR, one of the greatest public health inventions of our time, is at risk
Politics John Wilkerson STAT Plus: NIH nominee Bertagnolli will get a confirmation hearing next month, Sanders says
D.C. Diagnosis Rachel Cohrs STAT Plus: A new House health package & hospitals’ new site-neutral talking points
Politics Rachel Cohrs STAT Plus: House committees strike deal on health transparency, PBM reform package
Politics Rachel Cohrs STAT Plus: Astellas withdraws lawsuit after evading Medicare drug price negotiations
Health Lev Facher STAT Plus: Republicans say they’ll stop fentanyl at the border. But what are their plans for treatment?
First Opinion Andrea Ippolito STAT Plus: Why isn’t there any enforcement of the ACA mandate to support breastfeeding?
Politics Rachel Cohrs STAT Plus: The curious case of J&J’s Stelara, the unluckiest drug on Medicare’s list
Biotech Rachel Cohrs and Matthew Herper STAT Plus: Here are the 10 drugs that will be up first for Medicare price negotiation
First Opinion Joseph J. Fins STAT Plus: Every senator should fill out a legislative advance directive
D.C. Diagnosis Rachel Cohrs STAT Plus: Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis
Politics Damian Garde and Sarah Owermohle STAT Plus: Drugmakers already bet big on mRNA for cancer. Why is Biden going in, too?
Politics Damian Garde STAT Plus: Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Politics Sarah Owermohle and Lizzy Lawrence STAT Plus: Republican presidential candidates spar over abortion bans
Politics John Wilkerson STAT Plus: Ron DeSantis wants to import drugs from Canada. Biden’s FDA just blasted his plan
Politics Sarah Owermohle Republicans love RFK Jr. What does that tell us about their health platforms in 2024?
Matt's Take Matthew Herper STAT Plus: From drug shortages to high prices, U.S. system’s shortcomings have deep roots
Politics John Wilkerson STAT Plus: White House drug shortages task force MIA with lawmakers while Congress works on fixes
Politics Rachel Cohrs STAT Plus: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform
Politics Helen Branswell CDC director overhauls leadership of center that oversaw response to Covid-19